Perspective Study on How Can the Incentive Integrated E-IBD Chronic Disease Management Model Improve the Quality of Life in IBD Patients
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 200
- Locations
- 4
- Primary Endpoint
- Improved score of Quality of Life after three months
Study Overview
Brief Summary
This study aims to prospectively explore the effect of incentive-integrated E-IBD (electronic inflammatory bowel disease) chronic disease management model on the improvement of IBD quality of life, and provide a more effective chronic disease management model for improving the quality of life and social participation of IBD patients.The investigators firstly identify the IBD patients in need of empowerment disease activities through the questionnaire .Then, the investigators feedback the patients' education content according to their needs found.Based on the social support network of patient organization and the medical support network of tertiary medical institutions, the investigators complete the empowerment process of IBD patients' self-management initiative and self-management ability, through the internet. Finally ,the investigators evaluate the quality of life(QoL), social participation,disease self-management level via questionnaire . The primary outcome is the improvement of QoL score after three months' intervention.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 75 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •1.Clinically diagnosed IBD patients,according to the criteria of the Inflammatory Bowel Group of the Gastroenterology Branch of the Chinese Medical Association in 2018;
- •2.Aged 18 to 75 years old;
- •3.Understand and comply with the requirements of the program and sign informed consent.
- •4.Identified as need intervention according to the patient identification questionnaire screening;
- •5.Patients with the ability to complete all course training and/or follow-up work;
- •6.Enrolled at least one year ahead of end of this study(for garantee of enough folllow-up time).
Exclusion Criteria
- •1.Unable or unwilling to sign the consent form, or unable to follow the research procedure;
- •2.Patients who have had a stoma or ileorectal anastomosis (partial scales are not available);
- •3.Patients who do not complete training on time or do not complete follow-up assessments in their entirety;
- •4.Patients with other malignancies or life-threatening complications；
- •5.Pregnancy or lactation；
- •6.Patients whose remaining follow-up time less than one year before the end of this study.
Outcomes
Primary Outcomes
Improved score of Quality of Life after three months
Time Frame: three months
Improvement score of quality of life via short inflammatory bowel disease questionnaire(SIBDQ, score scale:0\~70 points) after intervention for three months,higher scores mean better quality of life.
Secondary Outcomes
- Increasion of disease kownledge(three months,one year)
- Decreased score of Socially activity limited rating(three months,one year)
- Decreased score of Hospital Anxiety and Depression Scale(three months,one year)